Regulation of interleukin-4 signaling by extracellular reduction of intramolecular disulfides.

[1]  J. Wood,et al.  Thioredoxin reductase activity at the surface of human primary cutaneous melanomas and their surrounding skin , 2007, International journal of cancer.

[2]  S. Holgate,et al.  IL-4 Receptor α Is an Important Modulator of IL-4 and IL-13 Receptor Binding: Implications for the Development of Therapeutic Targets1 , 2006, The Journal of Immunology.

[3]  J. Gibbins,et al.  Extracellular disulfide exchange and the regulation of cellular function. , 2006, Antioxidants & redox signaling.

[4]  I. Jones,et al.  Protein-disulfide Isomerase-mediated Reduction of Two Disulfide Bonds of HIV Envelope Glycoprotein 120 Occurs Post-CXCR4 Binding and Is Required for Fusion* , 2003, The Journal of Biological Chemistry.

[5]  C. Broder,et al.  Inhibitors of Protein-Disulfide Isomerase Prevent Cleavage of Disulfide Bonds in Receptor-bound Glycoprotein 120 and Prevent HIV-1 Entry* , 2002, The Journal of Biological Chemistry.

[6]  Kenneth M. Murphy,et al.  Decision making in the immune system: The lineage decisions of helper T cells , 2002, Nature Reviews Immunology.

[7]  C. Turano,et al.  Proteins of the PDI family: Unpredicted non‐ER locations and functions , 2002, Journal of cellular physiology.

[8]  P. Li,et al.  Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1 , 2002, Nature Immunology.

[9]  A. Shigematsu,et al.  Thioredoxin is associated with endotoxin tolerance in mice , 2002, Critical care medicine.

[10]  W. Busse,et al.  Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. , 2001, The Journal of allergy and clinical immunology.

[11]  Elias S. J. Arnér,et al.  Physiological functions of thioredoxin and thioredoxin reductase. , 2000, European journal of biochemistry.

[12]  M. Kashimura,et al.  Expression of thioredoxin and thioredoxin reductase in placentae of pregnant mice exposed to lipopolysaccharide. , 1999, Placenta.

[13]  K. Dabbagh,et al.  IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo. , 1999, Journal of immunology.

[14]  G. Aversa,et al.  Receptors and cytokines involved in allergic TH2 cell responses. , 1999, The Journal of allergy and clinical immunology.

[15]  P. Reinemer,et al.  Crystal Structure of the Interleukin-4/Receptor α Chain Complex Reveals a Mosaic Binding Interface , 1999, Cell.

[16]  P. Hogg,et al.  Redox Control of Exofacial Protein Thiols/Disulfides by Protein Disulfide Isomerase* , 1999, The Journal of Biological Chemistry.

[17]  K. Vasquez,et al.  Glutathione levels in antigen-presenting cells modulate Th1 versus Th2 response patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Kajiwara,et al.  A thiol antioxidant regulates IgE isotype switching by inhibiting activation of nuclear factor-kappaB. , 1997, The Journal of allergy and clinical immunology.

[19]  R. Pawankar,et al.  Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. , 1997, The Journal of clinical investigation.

[20]  Kenneth M. Murphy,et al.  Functional diversity of helper T lymphocytes , 1996, Nature.

[21]  J. Bonnefoy,et al.  Thiols decrease human interleukin (IL) 4 production and IL-4-induced immunoglobulin synthesis , 1995, The Journal of experimental medicine.

[22]  M. Schilsky,et al.  Secretion, Surface Localization, Turnover, and Steady State Expression of Protein Disulfide Isomerase in Rat Hepatocytes (*) , 1995, The Journal of Biological Chemistry.

[23]  E. Levy,et al.  Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[24]  D. S. Garrett,et al.  Three-dimensional solution structure of human interleukin-4 by multidimensional heteronuclear magnetic resonance spectroscopy. , 1993, Science.

[25]  R. Sitia,et al.  Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. , 1992, The Journal of biological chemistry.

[26]  W. Sebald,et al.  Site‐directed mutagenesis reveals the importance of disulfide bridges and aromatic residues for structure and proliferative activity of human Interleukin‐4 , 1991, FEBS letters.

[27]  M. Dean,et al.  Identification of a thioredoxin-related protein associated with plasma membranes. , 1991, Biochemical and biophysical research communications.

[28]  A. Levine,et al.  Disulfide assignments in recombinant mouse and human interleukin 4. , 1991, Biochemistry.

[29]  T. Yoshimori,et al.  Protein disulfide-isomerase in rat exocrine pancreatic cells is exported from the endoplasmic reticulum despite possessing the retention signal. , 1990, The Journal of biological chemistry.

[30]  K. Arai,et al.  ATL‐derived factor (ADF), an IL‐2 receptor/Tac inducer homologous to thioredoxin; possible involvement of dithiol‐reduction in the IL‐2 receptor induction. , 1989, The EMBO journal.

[31]  H. Hansson,et al.  Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats. , 1985, European journal of cell biology.

[32]  W. Buchanan,et al.  Disease-modifying drugs series editor : T. PULLAR AURANOFIN , 1997 .

[33]  A. Vazquez,et al.  N-acetylcysteine (NAC) enhances interleukin-2 but suppresses interleukin-4 secretion from normal and HIV+ CD4+ T-cells. , 1995, Cellular and molecular biology.

[34]  R. Coffman,et al.  Mechanism and regulation of immunoglobulin isotype switching. , 1993, Advances in immunology.